Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Metab ; 17: 61-70, 2018 11.
Article in English | MEDLINE | ID: mdl-30190193

ABSTRACT

OBJECTIVE: AMP activated protein kinase (AMPK) is recognized as an important nutrient sensor contributing to regulation of cellular, tissue, and systemic metabolism. We aimed to identify specific amino acids which could modulate AMPK and determine effects on cellular and systemic metabolism. METHODS: We performed an unbiased amino acid screen to identify activators of AMPK. Detailed analysis of cellular signaling and metabolism was performed in cultured hepatoma cells, and in vivo glucose metabolism and metabolomic patterns were assessed in both chow-fed mice and mice made obese by high-fat diet feeding. RESULTS: Alanine acutely activates AMP kinase in both cultured hepatic cells and in liver from mice treated in vivo with Ala. Oral alanine administration improves systemic glucose tolerance in both chow and high fat diet fed mice, with reduced efficacy of Ala in mice with reduced AMPK activity. Our data indicate that Ala activation of AMPK is mediated by intracellular Ala metabolism, which reduces TCA cycle metabolites, increases AMP/ATP ratio, and activates NH3 generation. CONCLUSIONS: Ala may serve as a distinct amino acid energy sensor, providing a positive signal to activate the beneficial AMPK signaling pathway.


Subject(s)
AMP-Activated Protein Kinases/metabolism , Alanine/pharmacology , Glucose/metabolism , Liver/drug effects , Adenosine Triphosphate/metabolism , Amino Acids/metabolism , Animals , Carbohydrate Metabolism , Carcinoma, Hepatocellular/metabolism , Cell Line , Diet, High-Fat , Hep G2 Cells , Humans , Lipid Metabolism/drug effects , Liver/metabolism , Liver Neoplasms/metabolism , Male , Mice , Mice, Inbred C57BL , Obesity
2.
Peptides ; 65: 12-9, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25620618

ABSTRACT

Obesity, type 2 diabetes and associated metabolic diseases are characterized by low-grade systemic inflammation which involves interplay of nutrition and monocyte/macrophage functions. We suggested that some factors such as nutrient components, neuropeptides involved in the control of gastrointestinal functions, and gastrointestinal hormones might influence immune cell functions and in this way contribute to the disease pathogenesis. The aim of this study was to investigate the mRNA expression of twelve nutrition-associated receptors in peripheral blood mononuclear cells (PBMC), isolated monocytes and monocyte-derived macrophages and their regulation under the switching from the high-carbohydrate low-fat diet to the low-carbohydrate high-fat (LC/HFD) isocaloric diet in healthy humans. The mRNA expression of receptors for short chain fatty acids (GPR41, GPR43), bile acids (TGR5), incretins (GIPR, GLP1R), cholecystokinin (CCKAR), neuropeptides VIP and PACAP (VIPR1, VIPR2), and neurotensin (NTSR1) was detected in PBMC and monocytes, while GPR41, GPR43, GIPR, TGR5, and VIPR1 were found in macrophages. Correlations of the receptor expression in monocytes with a range of metabolic and inflammatory markers were found. In non-obese subjects, the dietary switch to LC/HFD induced the increase of GPR43 and VIPR1 expression in monocytes. No significant differences of receptor expression between normal weight and moderately obese subjects were found. Our study characterized for the first time the expression pattern of nutrition-associated receptors in human blood monocytes and its dietary-induced changes linking metabolic responses to nutrition with immune functions in health and metabolic diseases.


Subject(s)
Dietary Carbohydrates/administration & dosage , Dietary Fats/administration & dosage , Gene Expression Regulation/drug effects , Macrophages/drug effects , Monocytes/drug effects , Obesity/genetics , Adult , Case-Control Studies , Cholecystokinin/genetics , Cholecystokinin/metabolism , Diet, Fat-Restricted , Diet, High-Fat , Female , Humans , Incretins/genetics , Incretins/metabolism , Macrophages/metabolism , Male , Monocytes/metabolism , Neuropeptides/genetics , Neuropeptides/metabolism , Obesity/blood , Organ Specificity , Primary Cell Culture , Receptors, Cell Surface/genetics , Receptors, Cell Surface/metabolism , Receptors, G-Protein-Coupled/genetics , Receptors, G-Protein-Coupled/metabolism , Receptors, Neurotensin/genetics , Receptors, Neurotensin/metabolism
3.
Nat Commun ; 5: 3563, 2014 Apr 08.
Article in English | MEDLINE | ID: mdl-24714520

ABSTRACT

D-Glucosamine (GlcN) is a freely available and commonly used dietary supplement potentially promoting cartilage health in humans, which also acts as an inhibitor of glycolysis. Here we show that GlcN, independent of the hexosamine pathway, extends Caenorhabditis elegans life span by impairing glucose metabolism that activates AMP-activated protein kinase (AMPK/AAK-2) and increases mitochondrial biogenesis. Consistent with the concept of mitohormesis, GlcN promotes increased formation of mitochondrial reactive oxygen species (ROS) culminating in increased expression of the nematodal amino acid-transporter 1 (aat-1) gene. Ameliorating mitochondrial ROS formation or impairment of aat-1-expression abolishes GlcN-mediated life span extension in an NRF2/SKN-1-dependent fashion. Unlike other calorie restriction mimetics, such as 2-deoxyglucose, GlcN extends life span of ageing C57BL/6 mice, which show an induction of mitochondrial biogenesis, lowered blood glucose levels, enhanced expression of several murine amino-acid transporters, as well as increased amino-acid catabolism. Taken together, we provide evidence that GlcN extends life span in evolutionary distinct species by mimicking a low-carbohydrate diet.


Subject(s)
Aging/drug effects , Caenorhabditis elegans/drug effects , Caenorhabditis elegans/physiology , Glucosamine/pharmacology , Longevity/drug effects , Animals , Female , Hep G2 Cells , Humans , Male , Mice , Mice, Inbred C57BL
4.
Nat Chem Biol ; 9(11): 693-700, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24077178

ABSTRACT

Sirtuins, a family of histone deacetylases, have a fiercely debated role in regulating lifespan. In contrast with recent observations, here we find that overexpression of sir-2.1, the ortholog of mammalian SirT1, does extend Caenorhabditis elegans lifespan. Sirtuins mandatorily convert NAD(+) into nicotinamide (NAM). We here find that NAM and its metabolite, 1-methylnicotinamide (MNA), extend C. elegans lifespan, even in the absence of sir-2.1. We identify a previously unknown C. elegans nicotinamide-N-methyltransferase, encoded by a gene now named anmt-1, to generate MNA from NAM. Disruption and overexpression of anmt-1 have opposing effects on lifespan independent of sirtuins, with loss of anmt-1 fully inhibiting sir-2.1-mediated lifespan extension. MNA serves as a substrate for a newly identified aldehyde oxidase, GAD-3, to generate hydrogen peroxide, which acts as a mitohormetic reactive oxygen species signal to promote C. elegans longevity. Taken together, sirtuin-mediated lifespan extension depends on methylation of NAM, providing an unexpected mechanistic role for sirtuins beyond histone deacetylation.


Subject(s)
Caenorhabditis elegans Proteins/metabolism , Caenorhabditis elegans/physiology , Longevity , Niacinamide/metabolism , Sirtuins/metabolism , Animals , Caenorhabditis elegans/metabolism , Methylation , Niacinamide/chemistry , Sirtuins/genetics
5.
Aging Cell ; 12(3): 508-17, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23534459

ABSTRACT

Arsenite is one of the most toxic chemical substances known and is assumed to exert detrimental effects on viability even at lowest concentrations. By contrast and unlike higher concentrations, we here find that exposure to low-dose arsenite promotes growth of cultured mammalian cells. In the nematode C. elegans, low-dose arsenite promotes resistance against thermal and chemical stressors and extends lifespan of this metazoan, whereas higher concentrations reduce longevity. While arsenite causes a transient increase in reactive oxygen species (ROS) levels in C. elegans, co-exposure to ROS scavengers prevents the lifespan-extending capabilities of arsenite, indicating that transiently increased ROS levels act as transducers of arsenite effects on lifespan, a process known as mitohormesis. This requires two transcription factors, namely DAF-16 and SKN-1, which employ the metallothionein MTL-2 as well as the mitochondrial transporter TIN-9.1 to extend lifespan. Taken together, low-dose arsenite extends lifespan, providing evidence for nonlinear dose-response characteristics of toxin-mediated stress resistance and longevity in a multicellular organism.


Subject(s)
Arsenites/pharmacology , Caenorhabditis elegans/drug effects , Hormesis , Longevity/drug effects , Mitochondria/drug effects , Teratogens/pharmacology , 3T3 Cells , Animals , Caenorhabditis elegans/metabolism , Caenorhabditis elegans Proteins/metabolism , Cell Line , DNA-Binding Proteins/metabolism , Forkhead Transcription Factors , Hep G2 Cells , Humans , Metallothionein/metabolism , Mice , Mitochondria/metabolism , Oxidative Stress/drug effects , Reactive Oxygen Species , Superoxide Dismutase/metabolism , Transcription Factors/metabolism , Transcription, Genetic
6.
Aging (Albany NY) ; 2(10): 650-8, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20876939

ABSTRACT

Reduced telomere length and impaired telomerase activity have been linked to several diseases associated with senescence and aging. However, a causal link to metabolic disorders and in particular diabetes mellitus is pending. We here show that young adult mice which are deficient for the Terc subunit of telomerase exhibit impaired glucose tolerance. This is caused by impaired glucose-stimulated insulin secretion (GSIS) from pancreatic islets, while body fat content, energy expenditure and insulin sensitivity were found to be unaltered. The impaired secretion capacity for insulin is due to reduced islet size which is linked to an impaired replication capacity of insulin-producing beta-cells in Terc-deficient mice. Taken together, telomerase deficiency and hence short telomeres impair replicative capacity of pancreatic beta-cells to cause impaired insulin secretion and glucose intolerance, mechanistically defining diabetes mellitus as an aging-associated disorder.


Subject(s)
Blood Glucose/metabolism , Glucose Intolerance/genetics , Insulin/metabolism , Islets of Langerhans/metabolism , Telomerase/deficiency , Animals , Blood Glucose/drug effects , Body Composition/genetics , Carbon Dioxide/metabolism , Cell Proliferation , Energy Metabolism/genetics , Glucose Tolerance Test , Insulin/blood , Insulin/pharmacology , Insulin-Secreting Cells/pathology , Islets of Langerhans/pathology , Lipids/blood , Mice , Mice, Knockout , Oxidation-Reduction , RNA/genetics , Telomerase/genetics , Telomere/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...